retatrutide headache Intranasal retatrutide: nasal spray delivery, bioavailability, all you need to know Retatrutide side effects: What to

For some patients, this dose is sufficient long-term

COMBINATION OF THIAZOLIDINEDIONE AND DPPIV INHIBITOR (Table 2) Exenatide 10 g bid therapy for 6 weeks improved glycemic control (mean difference, -0.98%), reduced body weight (mean difference, -1.51 kg), and caused gastrointestinal symptoms more than placebo in 233 patients (exenatide group 121, placebo group 112) with type 2 diabetes mellitus that was suboptimally controlled with TZD metformin [25]

Another trend is that GLP-1 therapies are being used for more than diabetes and obesity

Fluid overload is another risk, especially for people with heart or kidney issues

10.1007/s00223-009-9220-3 27 Nuche-BerenguerB.Portal-NezS.MorenoP.GonzlezN.AcitoresA.Lpez-HerradnA.et al (2010)